These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 25711631)
1. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis. Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631 [TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy. Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447 [TBL] [Abstract][Full Text] [Related]
4. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis. Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315 [TBL] [Abstract][Full Text] [Related]
5. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma. Bhardwaj M; Sen S; Sharma A; Kashyap S; Chosdol K; Pushker N; Bajaj MS; Bakhshi S Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160 [TBL] [Abstract][Full Text] [Related]
6. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Herpel E; Jensen K; Muley T; Warth A; Schnabel PA; Meister M; Herth FJ; Dienemann H; Thomas M; Gottschling S Anticancer Res; 2011 Dec; 31(12):4491-500. PubMed ID: 22199321 [TBL] [Abstract][Full Text] [Related]
7. Expression of Shh and Wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: clinicopathologic study. Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):370-7. PubMed ID: 23249701 [TBL] [Abstract][Full Text] [Related]
8. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer. Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781 [TBL] [Abstract][Full Text] [Related]
9. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma. Eom DW; Hong SM; Kim G; Bae YK; Jang KT; Yu E Appl Immunohistochem Mol Morphol; 2015; 23(10):682-8. PubMed ID: 25710579 [TBL] [Abstract][Full Text] [Related]
11. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target. Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290 [TBL] [Abstract][Full Text] [Related]
12. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes. Roudi R; Korourian A; Shariftabrizi A; Madjd Z Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383 [TBL] [Abstract][Full Text] [Related]
13. Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance. Okudela K; Woo T; Mitsui H; Tajiri M; Masuda M; Ohashi K Pathol Int; 2012 Dec; 62(12):792-801. PubMed ID: 23252868 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid. Yunoki T; Miyakoshi A; Otsuka M; Hayashi A Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448 [TBL] [Abstract][Full Text] [Related]
15. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas. Li F; Zeng H; Ying K Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756 [TBL] [Abstract][Full Text] [Related]
16. ABCG2 is a potential marker of tumor-initiating cells in breast cancer. Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795 [TBL] [Abstract][Full Text] [Related]
17. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns. Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159 [TBL] [Abstract][Full Text] [Related]
18. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals. Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186 [TBL] [Abstract][Full Text] [Related]
19. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors. Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452 [TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma. Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]